The National Congress on the Future of Pharmaceuticals in Medical Care 2000
  Overview | Agenda | Sponsors | Privacy Policy | Contact Us | Past Congress Home | Main Home 

Agenda Overview

Day 1

Day 2

Day 3


Agenda : Overview

Wednesday, November 15, 2000
Preconference Symposium

Thursday, November 16 and Friday, November 17, 2000
National Congress


Clement Bezold Clement Bezold, Ph.D.
Institute for Alternative Futures
Alexandria, VA
Samuel Broder Samuel Broder, M.D.
Executive Vice President and Chief Medical Officer
Celera Genomics
Rockville, MD
Francis Collins Francis Collins, MD, Ph.D.
National Human Genome
Research Institute
Bethesda, MA
Raymond Gilmartin Raymond Gilmartin
Chairman, President and CEO
Merck & Co., Inc.
Whitehouse Station, NJ
William Haseltine William A. Haseltine, Ph.D.
Chairman and CEO
Human Genome Sciences
Rockville, MD
Charles N. (Chip) Kahn III Charles N. (Chip) Kahn III
The Health Insurance Association of America
Washington, D.C.
Edward Penhoek Edward Penhoek, Ph.D.
Dean, School of Public Health
University of California at Berkeley
Berkeley, CA
Robert Reischauer Robert D. Reischauer, Ph.D.
Senior Fellow
The Brookings Institute
Washington, DC
Barrett Toan Barrett Toan
President and Chief Executive Officer
Express Scripts, Inc.
Maryland Heights, MO
Gail Wilensky Gail Wilensky, Ph.D.
Chair, The Medicare Payment Advisory
Bethesda, MD
Karen Williams Karen Williams, Ph.D.
President, National Pharmaceutical Council
Reston, VA
Janet Woodcock Janet Woodcock, MD
Director, Center for Drug Evaluation and Research Food and Drug Administration
Rockville, MD



Back to Top

Overview | Agenda | Sponsors | Privacy Policy | Contact Us | Past Congress Home | Main Home